tiprankstipranks
Trending News
More News >
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market

Edgewise Therapeutics (EWTX) Income Statement

Compare
403 Followers

Edgewise Therapeutics Income Statement

Last quarter (Q3 2025), Edgewise Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Edgewise Therapeutics's net income was $-40.67M. See Edgewise Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -185.00K
Operating Expenses
$ 158.83M$ 114.36M$ 71.66M$ 43.22M$ 17.01M
Depreciation and Amortization
$ 2.29M$ 1.73M$ 538.00K$ 272.00K$ 185.00K
EBITDA
$ -156.54M$ -112.63M$ -71.12M$ -42.94M$ -17.01M
Operating Income
$ -158.83M$ -114.36M$ -71.66M$ -43.22M$ -17.19M
Other Income/Expenses
$ 25.02M$ 14.19M$ 4.02M$ 402.00K$ 69.00K
Pretax Income
$ -133.81M$ -100.16M$ -67.64M$ -42.81M$ -17.12M
Net Income
$ -133.81M$ -100.16M$ -67.64M$ -42.81M$ -17.05M
Per Share Metrics
Basic EPS
$ -1.45$ -1.57$ -1.26$ -0.86$ -0.35
Diluted EPS
$ -1.45$ -1.57$ -1.26$ -0.86$ -0.35
Weighted Average Shares Outstanding
92.41M 63.72M 53.59M 49.50M 49.22M
Weighted Average Shares Outstanding (Diluted)
92.41M 63.72M 53.59M 49.50M 49.22M
Currency in USD

Edgewise Therapeutics Earnings and Revenue History